Edgen Stock·Sep 28 2025, 17:40戻る
戻る
Adaptive Biotechnologies Shares Advance Following Upgraded Earnings Outlook and Strategic Platform Integration
Edgen Stock·Sep 28 2025, 17:40
[1] The Bull Case For Adaptive Biotechnologies (ADPT) Could Change Following Analyst Upgraded Earnings Outlook[2] Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year? - Nasdaq[3] Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience | Nasdaq